State policy influence on the early diffusion of buprenorphine in community treatment programs
Open Access
- 20 June 2008
- journal article
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 3 (1) , 17
- https://doi.org/10.1186/1747-597X-3-17
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Role of State Policies in the Adoption of Naltrexone for Substance Abuse TreatmentHealth Services Research, 2007
- The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clustersDrug and Alcohol Dependence, 2006
- Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availabilityDrug and Alcohol Dependence, 2006
- Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectorsJournal of Substance Abuse Treatment, 2006
- Medicaid Policies To Contain Psychiatric Drug CostsHealth Affairs, 2005
- Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field ExperienceThe American Journal on Addictions, 2004
- A SMALL STUDY OF TRAINING IN MOTIVATIONAL INTERVIEWING: DOES ONE WORKSHOP CHANGE CLINICIAN AND CLIENT BEHAVIOR?Behavioural and Cognitive Psychotherapy, 2001
- Manual-guided cognitive-behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community.Psychology of Addictive Behaviors, 2001
- The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational FieldsAmerican Sociological Review, 1983
- Institutionalized Organizations: Formal Structure as Myth and CeremonyAmerican Journal of Sociology, 1977